ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)


Share Price
$ 23.25
Change
1.32 (6.02 %)
Market Cap
$2,907.98 m
Proactive Investors - Run By Investors For Investors

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals (NASDAQ: ACAD) is a biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. We have a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis.

EPIC: ACAD
Market: NASDAQ:ACAD
52-week High/Low: $32.53 / $12.80
Sector: Pharmaceuticals
Market Cap: $2,907.98M
Website: www.acadia-pharm.com
col 3
col 4
col 5
col 6

ACADIA Pharmaceuticals Inc. Timeline

Market Reports Including ACAD

VIEW ALL
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use